A new proof-of-concept method reliably engineered a hotspot mutation of SF3B1, a gene-splicing gene, into diverse cancer cell lines, outperforming other contemporary editing approaches. Oncogenesis ...
A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene—commonly altered in prostate cancer ...
Scientists have uncovered new genetic clues that explain why some prostate cancers remain slow-growing while others become life-threatening. Scientists from UCLA, the University of Toronto and the ...
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay disease progression in men with specific DNA repair gene mutations. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results